Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition

Nucleic Acids Research

Volumn 44, Issue 6, 2016, Pages 2514-2527

  Chang, Hongyuan ^a,b   Liu, Yuwei ^a   Xue, Mengzhu ^a   Liu, Haiyue ^b,c   Du, Shaowei ^a,d   Zhang, Liwen ^a,b,e,f   Wang, Peng ^a,b,f  

^a SHANGHAI ADVANCED RESEARCH INSTITUTE   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^d SHANGHAI UNIVERSITY   (China)

^e SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^f SHANGHAITECH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS2; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTOME; UNCLASSIFIED DRUG; (+)-JQ1 COMPOUND; ANTINEOPLASTIC AGENT; AZEPINE DERIVATIVE; BRD4 PROTEIN, HUMAN; ETS2 PROTEIN, HUMAN; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE; HNF4A PROTEIN, HUMAN; JUNB PROTEIN, HUMAN; NUCLEAR PROTEIN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ETS 2; TRANSFORMING GROWTH FACTOR BETA; TRIAZOLE DERIVATIVE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RNA SEQUENCE; SURVIVAL RATE; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MORTALITY; PATHOLOGY; PHENOTYPE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; AZEPINES; CELL LINE, TUMOR; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE NUCLEAR FACTOR 4; HISTONES; HUMANS; LUNG NEOPLASMS; NUCLEAR PROTEINS; PHENOTYPE; PROTO-ONCOGENE PROTEIN C-ETS-2; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TRIAZOLES;

EID: 84963823239     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw126     Document Type: Article

References (45)

1. De Craene, B. and Berx, G. (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer, 13, 97-110.
2. Lamouille, S., Xu, J. and Derynck, R. (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol., 15, 178-196.
3. Thiery, J.P., Acloque, H., Huang, R.Y. and Nieto, M.A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871-890.
4. Yang, J. and Weinberg, R.A. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 14, 818-829.
5. Garber, K. (2008) Epithelial-to-mesenchymal transition is important to metastasis, but questions remain. J. Natl. Cancer Inst., 100, 232-233.
6. Ikushima, H. and Miyazono, K. (2010) TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer, 10, 415-424.
7. Massague, J. and Gomis, R.R. (2006) The logic of TGFbeta signaling. FEBS Lett., 580, 2811-2820.
8. Mullen, A.C., Orlando, D.A., Newman, J.J., Loven, J., Kumar, R.M., Bilodeau, S., Reddy, J., Guenther, M.G., DeKoter, R.P. and Young, R.A. (2011) Master transcription factors determine cell-type-specific responses to TGF-beta signaling. Cell, 147, 565-576.
9. Spitz, F. and Furlong, E.E. (2012) Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet., 13, 613-626.
10. Loven, J., Hoke, H.A., Lin, C.Y., Lau, A., Orlando, D.A., Vakoc, C.R., Bradner, J.E., Lee, T.I. and Young, R.A. (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell, 153, 320-334.
11. Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y., Kagey, M.H., Rahl, P.B., Lee, T.I. and Young, R.A. (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell, 153, 307-319.
12. Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-Andre, V., Sigova, A.A., Hoke, H.A. and Young, R.A. (2013) Super-enhancers in the control of cell identity and disease. Cell, 155, 934-947.
13. Revenu, C. and Gilmour, D. (2009) EMT 2.0: shaping epithelia through collective migration. Curr. Opin. Genet. Dev., 19, 338-342.
14. Chao, Y., Wu, Q., Acquafondata, M., Dhir, R. and Wells, A. (2012) Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron., 5, 19-28.
15. Theveneau, E. and Mayor, R. (2012) Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration. Dev. Biol., 366, 34-54.
16. Jordan, N.V., Johnson, G.L. and Abell, A.N. (2011) Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell cycle, 10, 2865-2873.
17. Yu, M., Bardia, A., Wittner, B.S., Stott, S.L., Smas, M.E., Ting, D.T., Isakoff, S.J., Ciciliano, J.C., Wells, M.N., Shah, A.M. et al. (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science, 339, 580-584.
18. Liu, J., Hu, G., Chen, D., Gong, A.Y., Soori, G.S., Dobleman, T.J. and Chen, X.M. (2013) Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncogenesis, 2, e73.
19. Zavadil, J. and Bottinger, E.P. (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 24, 5764-5774.
20. Xu, J., Lamouille, S. and Derynck, R. (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res., 19, 156-172.
21. Zhang, J.Y., Tian, X.J., Zhang, H., Teng, Y., Li, R.Y., Bai, F., Elankumaran, S. and Xing, J.H. (2014) TGF-beta-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Sci. Signal, 7, ra91.
22. Denzler, R., Agarwal, V., Stefano, J., Bartel, D.P. and Stoffel, M. (2014) Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol. Cell, 54, 766-776.
23. Langmead, B., Trapnell, C., Pop, M. and Salzberg, S.L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, R25.
24. Li, B. and Dewey, C.N. (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics, 12, 323.
25. Conesa, A., Nueda, M.J., Ferrer, A. and Talon, M. (2006) maSigPro: a method to identify significantly differential expression profiles in time-course microarray experiments. Bioinformatics, 22, 1096-1102.
26. Frith, M.C., Fu, Y., Yu, L., Chen, J.F., Hansen, U. and Weng, Z. (2004) Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res., 32, 1372-1381.
27. Schulz, M.H., Devanny, W.E., Gitter, A., Zhong, S., Ernst, J. and Bar-Joseph, Z. (2012) DREM 2.0: Improved reconstruction of dynamic regulatory networks from time-series expression data. BMC Syst. Biol., 6, 104.
28. Liu, T., Ortiz, J.A., Taing, L., Meyer, C.A., Lee, B., Zhang, Y., Shin, H., Wong, S.S., Ma, J., Lei, Y. et al. (2011) Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol., 12, R83.
29. Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E. et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2, 401-404.
30. Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E. et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal., 6, pl1.
31. Javaid, S., Zhang, J., Anderssen, E., Black, J.C., Wittner, B.S., Tajima, K., Ting, D.T., Smolen, G.A., Zubrowski, M., Desai, R. et al. (2013) Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of Snail-1. Cell Rep., 5, 1679-1689.
32. Evdokimova, V., Tognon, C., Ng, T., Ruzanov, P., Melnyk, N., Fink, D., Sorokin, A., Ovchinnikov, L.P., Davicioni, E., Triche, T.J. et al. (2009) Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell, 15, 402-415.
33. Hebenstreit, D., Fang, M., Gu, M., Charoensawan, V., van Oudenaarden, A. and Teichmann, S.A. (2011) RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol., 7, 497.
34. Stergachis, A.B., Neph, S., Sandstrom, R., Haugen, E., Reynolds, A.P., Zhang, M., Byron, R., Canfield, T., Stelhing-Sun, S., Lee, K. et al. (2014) Conservation of trans-acting circuitry during mammalian regulatory evolution. Nature, 515, 365-370.
35. Yeger-Lotem, E., Sattath, S., Kashtan, N., Itzkovitz, S., Milo, R., Pinter, R.Y., Alon, U. and Margalit, H. (2004) Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction. Proc. Natl. Acad. Sci. U.S.A., 101, 5934-5939.
36. Asangani, I.A., Dommeti, V.L., Wang, X., Malik, R., Cieslik, M., Yang, R., Escara-Wilke, J., Wilder-Romans, K., Dhanireddy, S., Engelke, C. et al. (2014) Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature, 510, 278-282.
37. Hein, M.Y., Hubner, N.C., Poser, I., Cox, J., Nagaraj, N., Toyoda, Y., Gak, I.A., Weisswange, I., Mansfeld, J., Buchholz, F. et al. (2015) A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell, 163, 712-723.
38. Lockwood, W.W., Zejnullahu, K., Bradner, J.E. and Varmus, H. (2012) Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Proc. Natl. Acad. Sci. U.S.A., 109, 19408-19413.
39. Alsarraj, J. and Hunter, K.W. (2012) Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix. Int. J. Breast Cancer, 2012, 670632.
40. Hu, Y., Zhou, J., Ye, F., Xiong, H., Peng, L., Zheng, Z., Xu, F., Cui, M., Wei, C., Wang, X. et al. (2015) BRD4 inhibitor inhibits colorectal cancer growth and metastasis. Int. J. Mol. Sci., 16, 1928-1948.
41. Yang, M., Li, S.N., Anjum, K.M., Gui, L.X., Zhu, S.S., Liu, J., Chen, J.K., Liu, Q.F., Ye, G.D., Wang, W.J. et al. (2013) A double-negative feedback loop between Wnt-beta-catenin signaling and HNF4alpha regulates epithelial-mesenchymal transition in hepatocellular carcinoma. J. Cell Sci., 126, 5692-5703.
42. Gervasi, M., Bianchi-Smiraglia, A., Cummings, M., Zheng, Q., Wang, D., Liu, S. and Bakin, A.V. (2012) JunB contributes to Id2 repression and the epithelial-mesenchymal transition in response to transforming growth factor-beta. J. Cell Biol., 196, 589-603.
43. Polydorou, C. and Georgiades, P. (2013) Ets2-dependent trophoblast signalling is required for gastrulation progression after primitive streak initiation. Nat. Commun., 4, 1658.
44. Darnell, J.E. Jr (2002) Transcription factors as targets for cancer therapy. Nat. Rev. Cancer, 2, 740-749.
45. Vaquerizas, J.M., Kummerfeld, S.K., Teichmann, S.A. and Luscombe, N.M. (2009) A census of human transcription factors: function, expression and evolution. Nat. Rev. Genet., 10, 252-263.